Nektar Therapeutics reported $-152836000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
ALKERMES ALKS:US -34457000 7.87M
Amgen AMGN:US $ 2176M 324M
Astrazeneca AZN:US 539M 339M
Baxter International BAX:US $ 351M 188M
Biocryst Pharmaceuticals BCRX:US $ -34.72M 15.24M
Biogen BIIB:US $ -59.1M 669.8M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Bristol Myers Squibb BMY:US $ 2590M 37M
Cara Therapeutics CARA:US $ -4472000 23.44M
Dr.Reddys Laboratories DRRD:IN 6.39B 4.81B
Eisai 4523:JP Y 7434M 28237M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Exelixis EXEL:US $ 83.71M 0.46M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Immunogen IMGN:US $ -61.05M 38.2M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Ironwood Pharmaceuticals IRWD:US $ 55.66M 2.19M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Merk MRK:US $ 4927M 642M
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Novartis NOVN:VX 2.23B 624M
Pfizer PFE:US $ 12102M 2229M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Takeda 4502:JP Y 150515M 152134M
Teva Pharmaceutical TEVA:IT -949000000 236M
Xencor XNCR:US $ -28M 54.47M
YTE INCY:US $ 254.43M 137.89M